1. Articles from biospace.com

  2. 49-72 of 81 « 1 2 3 4 »
    1. Billionaire Businessman Looking to Take Stake in Debt-Ridden Teva

      Billionaire Businessman Looking to Take Stake in Debt-Ridden Teva

      Shares of Teva Pharmaceuticals are up more than 5 percent this morning after Israeli media reported billionaire businessman Len Blavatnik is considering taking a large stock position in the pharma giant. Citing multiple Israeli media outlets, Reuters reported Blavatnik “has been examining a large share purchase in Teva.” According to reports, Blavatnik could invest up to $3 billion in Teva...

      Read Full Article
    2. Why Ex-Ariad CEO Joining This Biotech's Board Could Mean a Buyout Deal Is Coming

      Why Ex-Ariad CEO Joining This Biotech's Board Could Mean a Buyout Deal Is Coming

      The former CEO of Ariad Pharmaceuticals Inc., who spent the last year shaping up the Cambridge-based drug company for its $5.2 acquisition earlier this year, was just named to the board of a new biotech last week. There, as the newest board member of New Jersey-based The Medicines Company, Paris Panayiotopoulos joins a familiar face: Alex Denner, former chairman of Ariad (Nasdaq: ARIA)...

      Read Full Article
      Mentions: MDC Partners
    3. Kite Pharma Announces Appointment Of Renowned Cancer Researcher, M.D., To Its Board Of Directors

      Kite Pharma Announces Appointment Of Renowned Cancer Researcher, M.D., To Its Board Of Directors

      Kite Pharma, Inc. today announced that Owen N. Witte, M.D., the founding director of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at the University of California Los Angeles and a renowned cancer researcher, has been appointed to its Board of Directors...

      Read Full Article
    4. Biohaven Closes Second Tranche Of Private Placement And Appoints Two New Directors To Board

      Biohaven Closes Second Tranche Of Private Placement And Appoints Two New Directors To Board

      Biohaven Pharmaceutical Holding Company Ltd. ("Biohaven"), a privately-held, clinical stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological diseases, including rare disorders, announced today that it has completed the second tranche of its previously disclosed $80 million private financing...

      Read Full Article
    5. Herb Boyer PhD Joins Banyan Biomarkers Board Of Directors

      Herb Boyer PhD Joins Banyan Biomarkers Board Of Directors

      Banyan Biomarkers, Inc., a pioneer in developing biomarkers for traumatic brain injury, today announced that Herb Boyer, PhD, co-founder of Genentech, will serve on the Banyan Biomarkers’ Board of Directors. Dr. Boyer co-founded Genentech in 1976 and served as a director of the company until its 2008 acquisition by Roche. He also was a vice president of the company from 1976 to 1990...

      Read Full Article
    6. PhotoSonix Medical Appoints Former NeoStrata CEO Mark D. Steele To Board Of Directors

      PhotoSonix Medical Appoints Former NeoStrata CEO Mark D. Steele To Board Of Directors

      PhotoSonix Medical, Inc. a medical technology company transforming the treatment of acne, announced that Mark D. Steele has joined the Company's Board of Directors. Mr. Steele joins a distinguished Board of industry leaders in their pursuit to deliver a new level of efficacy to millions of patients who suffer from acne. Mr. Steele is a 30-year veteran of the dermatology and consumer products industries...

      Read Full Article
    7. Dr Joins Minoryx Therapeutics As Independent Board Member

      Dr Joins Minoryx Therapeutics As Independent Board Member

      Minoryx Therapeutics, a drug development company specialized in the discovery of new drugs for orphan diseases, today announces that Dr Claude Nicaise has joined its board of directors as an independent member. Dr Nicaise has over 30 years' experience in developing worldwide regulatory strategy in the pharmaceutical and biotechnology industries...

      Read Full Article
    8. True North Therapeutics Appoints Biotechnology Commercial Executive to its Board Of Directors

      True North Therapeutics Appoints Biotechnology Commercial Executive to its Board Of Directors

      True North Therapeutics, a clinical stage biotechnology company developing novel product candidates that selectively inhibit the Complement system, today announced that the company has appointed Jeff Ajer, Executive Vice President and Chief Commercial Officer of BioMarin, as an independent director to the company’s board of directors...

      Read Full Article
    9. Cellectis Release: Four Prominent Physicians To Join Clinical Advisory Board

      Cellectis Release: Four Prominent Physicians To Join Clinical Advisory Board

      Cellectis, a biopharmaceutical company focused on developing immunotherapies based on gene edited CAR T-cells, today announced that four new members joined Cellectis’ Clinical Advisory Board (CAB). The CAB serves as a strategic resource to Cellectis as the Company enters the clinical development of allogeneic CAR T immunotherapies lead by its wholly owned product candidate, UCART123...

      Read Full Article
      Mentions: Advisory Boards
    10. Decibel Therapeutics Expands Leadership Team With World-Class Bioinformatics Scientist; Appoints Three New Members To Its Board Of Directors

      Decibel Therapeutics Expands Leadership Team With World-Class Bioinformatics Scientist; Appoints Three New Members To Its Board Of Directors

      Decibel Therapeutics, a company focused on discovering and developing new therapies to protect, repair, and restore hearing, today announced that it has expanded its leadership team with the addition of chief data sciences officer John Keilty. Decibel has also appointed three new members to its board of directors: Troyen A. Brennan, M.D., M.P.H., executive vice president and chief medical officer, CVS Health; Roger H. Brown, president, Berklee College of Music; and George A. Scangos, Ph.D., chief executive officer, Vir Biotechnologies, Inc...

      Read Full Article
      Mentions: Leadership
    11. Landauer Release: Company Agrees To Appoint To Board Of Directors And Announces Agreement With

      Landauer Release: Company Agrees To Appoint To Board Of Directors And Announces Agreement With

      Landauer, Inc., a recognized leader in personal and environmental radiation measurement and monitoring and outsourced medical physics services, today announced that the Company has expanded the Company's Board of Directors from nine to ten directors and appointed Jeffrey A. Strong to the Board to fill the resulting vacancy...

      Read Full Article
    12. Audentes Appoints To Board Of Directors

      Audentes Appoints To Board Of Directors

      Audentes Therapeutics, Inc. (Nasdaq: BOLD), a biotechnology company focused on developing and commercializing gene therapy products for patients living with serious, life-threatening rare diseases, today announced the appointment of Julie Anne Smith to its board of directors. "We are delighted to welcome Julie to our board of directors," stated Matthew Patterson , President and Chief Executive Officer.

      Read Full Article
    13. Cell MedX Corp Appoints Gregory Pek To The Advisory Board

      Cell MedX Corp., a development stage bio-tech company focused on the commercialization and development of microcurrent therapeutic devices that promote general wellness and alleviate complications associated with medical conditions including, but not limited to, diabetes, Parkinson's disease, high blood pressure, is pleased to announce that it has appointed Gregory Pek to the Company's advisory board and as a distributor for Hong Kong and the Philippines. Gregory Pek is a Canadian who has lived in Asia for some 22 ...

      Read Full Article
    14. Enanta Pharmaceuticals, Inc. Announces The Appointment Of Dr. Lesley Russell To Its Board Of Directors

      Enanta Pharmaceuticals, Inc. Announces The Appointment Of Dr. Lesley Russell To Its Board Of Directors

      Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced the appointment of Lesley Russell, MBChB, MRCPb, to its Board of Directors. Dr. Russell will also serve as a member of Enanta’s audit committee and its nominating and corporate governance committee, effective as of January 1, 2017 ...

      Read Full Article
    15. Synthetic Genomics, Inc. Appoints Tina Nova, Ph.D., And William McKee To Board Of Directors

      Synthetic Genomics, Inc. Appoints Tina Nova, Ph.D., And William McKee To Board Of Directors

      Synthetic Genomics, Inc., announced today that it has appointed industry veterans Tina Nova , Ph.D., and William McKee to its board of directors. "Tina and Bill have decades of experience growing dynamic commercial organizations in new markets within the pharmaceutical and healthcare diagnostics industries," said Oliver Fetzer , Ph.D., chief executive officer of Synthetic Genomics ...

      Read Full Article
    49-72 of 81 « 1 2 3 4 »
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Question of The Week, Sponsored Content